Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 249.95M | 249.76M | 260.06M | 239.60M | 286.20M |
| Total Receivables | 101.10M | 98.07M | 85.17M | 76.43M | 87.63M |
| Inventory | 118.78M | 115.34M | 81.32M | 60.76M | 59.70M |
| Prepaid Expenses | 34.91M | 35.31M | 35.15M | 54.44M | 49.53M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 504.74M | 498.47M | 461.70M | 431.24M | 483.06M |
|
|
|||||
| Total Current Assets | 504.74M | 498.47M | 461.70M | 431.24M | 483.06M |
| Net Property, Plant & Equipment | 51.66M | 53.58M | 53.77M | 55.42M | 57.98M |
| Long-term Investments | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Total Other Intangibles | 17.20M | 18.03M | 18.85M | 19.67M | 20.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.64M | 18.68M | 17.36M | 17.66M | 18.55M |
| Total Assets | 785.03M | 786.56M | 749.48M | 721.79M | 777.88M |
|
|
|||||
| Total Accounts Payable | 12.95M | 13.48M | 32.06M | 9.21M | 15.12M |
| Total Accrued Expenses | 100.49M | 132.89M | 125.64M | 124.62M | 121.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.46M | 8.54M | 8.11M | 8.27M | 8.32M |
| Total Finance Division Other Current Liabilities | 26.81M | 3.23M | 2.26M | -- | 22.81M |
| Total Other Current Liabilities | 26.81M | 3.23M | 2.26M | -- | 22.81M |
| Total Current Liabilities | 148.70M | 158.14M | 168.07M | 142.10M | 167.69M |
|
|
|||||
| Total Current Liabilities | 148.70M | 158.14M | 168.07M | 142.10M | 167.69M |
| Long-Term Debt | 390.11M | 389.49M | 388.94M | 388.39M | 387.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.08M | 46.62M | 47.01M | 47.83M | 48.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.10M | 13.48M | 12.95M | 12.77M | 13.28M |
| Total Liabilities | 590.99M | 607.73M | 616.96M | 591.10M | 617.71M |
|
|
|||||
| Common Stock & APIC | 2.93B | 2.91B | 2.87B | 2.86B | 2.84B |
| Retained Earnings | -2.74B | -2.75B | -2.75B | -2.73B | -2.68B |
| Treasury Stock & Other | 5.17M | 25.04M | 8.87M | 6.72M | 5.31M |
| Total Common Equity | 194.05M | 178.83M | 132.52M | 130.69M | 160.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 194.05M | 178.83M | 132.52M | 130.69M | 160.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 194.05M | 178.83M | 132.52M | 130.69M | 160.17M |
|
|
|||||